Table 3. Dermatological control and skin cancer risk factors evaluation.

N = 5530	n	%	CI 95%
Users receiving dermatological assessment	2370	42.9%	41.6%:44.2%
Who were examined by:
General practitioner	273	4.9%	4.4%:5.5%
with Total Body Skin Exploration	64	1.2%	0.9%:1.4%
Dermatologist	2122	38.4%	37.9%:38.9%
with Total Body Skin Exploration	1049	19.0%	18.7%:19.2%
Others	53	1.0%	0.7%:1.2%
Uncertain	31	0.6%	0.4%:0.8%
Skin cancer risk evaluation
Users with skin cancer familial history	650	11.8%	10.9%:12.6%
Users with skin cancer personal history	342	6.2%	5.5%:6.8%
Users with skin with > 10 melanocytic nevus on one arm	2423	43.8%	42.5%:45.1%
Users with chronically sun:damaged skin	1184	21.4%	20.3%:22.5%
Users with self:reported skin cancer lesions compared to an atlas	604	10.9%	10.1%:11.7%
Users with pharmaceutical recommendations:
R1. Risk factor(s) detected: GP referral.	2982	53.9%	53.1%:54.7%
R2. Self:reported suspicious lesions: urgent referral.	604	10.9%	10.1%:11.8%